Intraoperative radiation therapy: is it a standard now? (Q37947884)

25 August 2017

Intraoperative radiation therapy: is it a standard now? (English)

1 reference

intraoperative radiation therapy

25 August 2017

0 references

1 reference

1

Roberto Orecchia

1 reference

25 August 2017

Maria Cristina Leonardo

series ordinal

2

1 reference

25 August 2017

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

20 Suppl 3

1 reference

25 August 2017

S111-5

1 reference

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Integrated breast conservation and intraoperative radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

A dosimetric comparison of IORT techniques in limited-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Biologic comparison of partial breast irradiation protocols.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working gr

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970307-1

7 January 2021

10.1016/S0960-9776(11)70307-1

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22015276